Has Chad McCormick, MD received payments from drug or device companies?

Yes. Drug and device makers reported $246 in general payments to Chad McCormick, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chad McCormick, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chad McCormick, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chad McCormick, MD

Otolaryngology · Post Falls, IDNPI 1538165139

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $196 of the $246 with a category attached, or 79.7%. 7 manufacturers reported payments, led by Intersect ENT, Inc. at 33.6% of the total. That places this record below the midpoint for otolaryngology clinicians in ID, where the typical reported total is $471.

$246in general payments, 2019–2025

Across 8 payments — averaging $30.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intersect ENT, Inc.$82
Medtronic$50
Xoran Technologies LLC$41
Inspire Medical Systems, Inc.$19
Aerin Medical Inc.$18
Johnson & Johnson$18
plus $17 from 1 others

What the payments were for

Consulting fees$5020%
Food & beverage$19680%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intersect ENT, Inc.	2	$82
Medtronic	1	$50
Xoran Technologies LLC	1	$41
Inspire Medical Systems, Inc.	1	$19
Aerin Medical Inc.	1	$18
Johnson & Johnson	1	$18
Kaleo, Inc.	1	$17

How this compares

$246 in reported general payments places this provider in the 40th percentile of 40 otolaryngology providers in Idaho.

See all otolaryngology providers in Idaho →

Medicare billing

Part B allowed, 2024

$106,991

Medicare patients

388

Services billed

2,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	27	$1,362
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	11	$961
Fluticasone Propionate	56	$840
Fluocinolone Acetonide Oil	11	$248
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	18	$98
Omeprazole	15	$66
Prednisone	16	$23

Paid to pharmacies, not to this prescriber.